Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
Authors:
- Tantan LiuTLTantan Liu
- Yingmei WangYWYingmei Wang
- Shuai ShaoSSShuai Shao
- Weichen ZhangWZWeichen Zhang
- Yang LvYLYang Lv
- Jun YiJYJun Yi
- Zhe WangZWZhe Wang
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 13 (1) , 53-60
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast CancerFrontiers in Oncology, 2012
- Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast CancerInternational Journal of Breast Cancer, 2012
- Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumourThe Breast, 2011
- Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case ReportCase Reports in Oncology, 2011
- Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival OutcomesClinical Cancer Research, 2009
- Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancerBritish Journal of Cancer, 2009
- Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)Annals of Oncology, 2009
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancerEuropean Journal of Cancer, 2003